Clinical trial
Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)
NCT02109887 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)
- Lead sponsor
- Asan Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- December 31, 2016
- Enrollment
- 76 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-hiv patients with pneumocystis jiroveci pneumonia